Apple loses top spot in China smartphone sales

iPhone No Longer Top-Selling Smartphone in China
Apple lost the top spot in the Chinese smartphone market after a domestic brand replaced the iPhone as the country's top choice.
Apple dethroned as top smartphone seller in China, replaced by Vivo & Huawei
Apple is no longer the top smartphone seller in China, overtaken by Vivo and Huawei, with a 17% market share decline in 2024. Apple now holds 15%, marking its worst annual performance in the country.
Apple loses top spot in China smartphone sales to local rivals
Apple loses top spot in China smartphone sales to local rivals Apple lost its status as the best selling smartphone brand in the crucial Chinese market last year, new data showed Thursday, with a pair of local rivals surpassing it with surging shipments.
Apple has ‘worst annual performance’ in China as smaller rivals dethrone iPhone champ
Apple was dethroned as China’s biggest smartphone seller in 2024, with local rivals Vivo and Huawei overtaking the iPhone maker after its annual shipments in the country declined 17%, data from research firm Canalys showed on Thursday.
Apple tumbles as research firm shows iPhone lost its top spot in China in 2024
Apple (NASDAQ:AAPL) shares fell 4% in midday trading on Thursday after research firm Canalys showed the iPhone lost the top spot in the smartphone market to local rivals, including Vivo and Huawei Technologies.
iPhone drops from 1st to 3rd place in China, as Apple struggles to launch AI features
The iPhone has lost its crown as the best-selling phone in China, dropping to 3rd place in the latest market intelligence ...
Foreign-branded smartphones are losing a lot of ground in China
Data from a government-affiliated research firm show an almost 50% year-on-year decline in shipments of foreign-branded ...
EconoTimes4d
Global Smartphone Market Sees Shifts as Chinese Brands Gain Ground
Smartphone shipments for Apple (NASDAQ:AAPL) and Samsung (KS:005930) declined in Q4 as competition from Chinese companies like Xiaomi (OTC:XIACF) intensified, according to preliminary data from IDC.